Skip to main content
. Author manuscript; available in PMC: 2014 Sep 28.
Published in final edited form as: Cancer Lett. 2013 Apr 11;338(2):267–270. doi: 10.1016/j.canlet.2013.04.001

Table 3.

Levels of pyrimidine base damage are listed in terms of femtomoles of lesion per microgram of DNA ± SEM. The number in parenthesis is the number of participants in the group.

Ovarian Cancer Patients (19) 6.3 ± 0.8 2.8 ± 0.5
Controls (16) 5.5 ± 0.8 2.2± 0.4